Condition: Spinal Metastases · Blood Transfusion Complication · Lung Cancer · Sponsor: Guangdong Provincial People's Hospital
The goal of this single-center prospective randomized controlled trial is to test and compare the safety and effectiveness of autologous blood transfusion in spinal surgery for lung cancer spinal metastases. The main questions it aims to answer are: * Does autologous blood transfusion increase the incidence of new metastases? * Does autologous blood transfusion affect postoperative hemoglobin levels and the number of circulating tumor cells in the blood? * Can autologous blood transfusion reduce the rate of allogeneic transfusion during and after surgery for spinal metastases?
This description comes directly from the study's public registry record.
Yu Zhang, Ph.D. · 8613602744495 · luck_2001@126.com
Guoqing Zhong, M.D. · 8613417005047 · gqzhong@foxmail.com
Always discuss trial participation with your own doctor first.
| Guangdong provincial people's hospital | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06244264